New YouTube Policy Targets Cancer Misinformation
Online misinformation is harming cancer patients. YouTube has been part of the problem, but a new policy might change that.
Diagnosis & Disease Information
Oncologists Receive More EHR Messages Than Other HCPs but Spend Less Time in EHRs
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Dose-Intensive Chemoimmunotherapy “Preferred” for Untreated PMBCL
Dose-intensive chemoimmunotherapy may be more effective than standard chemoimmunotherapy in PMBCL, a meta-analysis suggests.
Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths
Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.
Global Incidence of Early-Onset Cancers Rose 80% From 1990 to 2019
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.
Loncastuximab Tesirine Elicits Lasting Responses in Relapsed/Refractory DLBCL
Loncastuximab tesirine produced durable responses in a phase 2 trial of patients with relapsed or refractory DLBCL.
Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Billing for Patient Portal Messages Reduces Docs’ Workloads but May Increase Financial Toxicity for Cancer Patients
Cancer patients are increasingly messaging their oncology care teams through patient portals, but many health systems have started to bill for this messaging.
Some Immunosuppressed Patients Lack Anti-Spike Antibodies After Multiple COVID-19 Vaccinations
About 1 in 5 immunosuppressed individuals have no detectable IgG anti-spike antibodies after 3 or more COVID-19 vaccinations, a new study suggests.
Five Things to Know About the New Drug Pricing Negotiations
The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...